These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 24764662)
1. Multimodal imaging evaluation in staging of rectal cancer. Heo SH; Kim JW; Shin SS; Jeong YY; Kang HK World J Gastroenterol; 2014 Apr; 20(15):4244-55. PubMed ID: 24764662 [TBL] [Abstract][Full Text] [Related]
2. Current trends in staging rectal cancer. Samee A; Selvasekar CR World J Gastroenterol; 2011 Feb; 17(7):828-34. PubMed ID: 21412492 [TBL] [Abstract][Full Text] [Related]
3. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy. Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812 [TBL] [Abstract][Full Text] [Related]
4. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714 [TBL] [Abstract][Full Text] [Related]
5. Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management. Balyasnikova S; Brown G Curr Treat Options Oncol; 2016 Jun; 17(6):32. PubMed ID: 27255100 [TBL] [Abstract][Full Text] [Related]
6. Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment. Hunter CJ; Garant A; Vuong T; Artho G; Lisbona R; Tekkis P; Abulafi M; Brown G Ann Surg Oncol; 2012 Apr; 19(4):1199-205. PubMed ID: 21913017 [TBL] [Abstract][Full Text] [Related]
7. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease. Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience. Crimì F; Spolverato G; Lacognata C; Garieri M; Cecchin D; Urso ED; Zucchetta P; Pucciarelli S; Pomerri F Dis Colon Rectum; 2020 Mar; 63(3):310-318. PubMed ID: 31842163 [TBL] [Abstract][Full Text] [Related]
9. Rectal cancer: primary staging and assessment after chemoradiotherapy. Evans J; Patel U; Brown G Semin Radiat Oncol; 2011 Jul; 21(3):169-77. PubMed ID: 21645861 [TBL] [Abstract][Full Text] [Related]
10. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer]. Wang Y; Chen G Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307 [TBL] [Abstract][Full Text] [Related]
11. Relative Value of Restaging MRI, CT, and FDG-PET Scan After Preoperative Chemoradiation for Rectal Cancer. Schneider DA; Akhurst TJ; Ngan SY; Warrier SK; Michael M; Lynch AC; Te Marvelde L; Heriot AG Dis Colon Rectum; 2016 Mar; 59(3):179-86. PubMed ID: 26855391 [TBL] [Abstract][Full Text] [Related]
12. MRI for Rectal Cancer Primary Staging and Restaging After Neoadjuvant Chemoradiation Therapy: How to Do It During Daily Clinical Practice. Cianci R; Cristel G; Agostini A; Ambrosini R; Calistri L; Petralia G; Colagrande S Eur J Radiol; 2020 Oct; 131():109238. PubMed ID: 32905955 [TBL] [Abstract][Full Text] [Related]
13. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Song I; Kim SH; Lee SJ; Choi JY; Kim MJ; Rhim H Br J Radiol; 2012 May; 85(1013):577-86. PubMed ID: 21343320 [TBL] [Abstract][Full Text] [Related]
14. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308 [No Abstract] [Full Text] [Related]
15. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer? Li YL; Wu LM; Chen XX; Delproposto Z; Hu JN; Xu JR J Dig Dis; 2014 Oct; 15(10):525-37. PubMed ID: 25060294 [TBL] [Abstract][Full Text] [Related]
16. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma. Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer. Cho YB; Chun HK; Kim MJ; Choi JY; Park CM; Kim BT; Lee SJ; Yun SH; Kim HC; Lee WY World J Surg; 2009 Dec; 33(12):2688-94. PubMed ID: 19823904 [TBL] [Abstract][Full Text] [Related]
18. How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy? De Nardi P; Carvello M World J Gastroenterol; 2013 Sep; 19(36):5964-72. PubMed ID: 24106396 [TBL] [Abstract][Full Text] [Related]
20. Factors affecting the restaging accuracy of magnetic resonance imaging after preoperative chemoradiation in patients with rectal cancer. Kim IY; Cha SW; Ahn JH; Kim YW Eur J Surg Oncol; 2015 Apr; 41(4):493-8. PubMed ID: 25648465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]